Cargando…

CD34(+) Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy

We investigated the effects of CD34(+) cell therapy on right ventricular (RV) function in patients with nonischemic dilated cardiomyopathy (DCM). We enrolled 60 patients with DCM who were randomized to CD34(+) cell therapy (Stem Cells (SC) Group n = 30), or no cell therapy (Controls, n = 30). The SC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frljak, Sabina, Jaklic, Martina, Zemljic, Gregor, Cerar, Andraz, Poglajen, Gregor, Vrtovec, Bojan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Human Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788875/ https://www.ncbi.nlm.nih.gov/pubmed/29380563 http://dx.doi.org/10.1002/sctm.17-0197

Ejemplares similares

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

Transendocardial CD34(+) Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case Study
por: Cerar, Andraz, et al.
Publicado: (2018)

Transendocardial CD34(+) Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy
por: Žorž, Neža, et al.
Publicado: (2022)

Effects of Transendocardial CD34(+) Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
por: Bervar, Mojca, et al.
Publicado: (2017)

Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2018)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
por: Poglajen, Gregor, et al.
Publicado: (2020)

A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction
por: Vrtovec, Bojan, et al.
Publicado: (2022)

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
por: Cerar, Andraz, et al.
Publicado: (2020)

Response to the letter to the editor: unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion
por: Cerar, Andraz, et al.
Publicado: (2020)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
por: Frljak, Sabina, et al.
Publicado: (2022)

(651) Long-Term Safety and Efficacy of Mrna Sars-Cov2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2023)

Outcomes of COVID-19 in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022)

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review
por: Hoeeg, Cecilie, et al.
Publicado: (2020)

TNF-α Predicts Endothelial Function and Number of CD34(+) Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure
por: Ugovšek, Sabina, et al.
Publicado: (2022)

Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Predictors of Right Ventricular Ejection Fraction in Patients with Nonischemic Cardiomyopathy
por: Sabe, Sharif A, et al.
Publicado: (2016)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
por: Banovic, Marko, et al.
Publicado: (2022)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
por: Okubo, Kenji, et al.
Publicado: (2018)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
por: Lawson, Mark A., et al.
Publicado: (2021)

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2023)

T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy
por: Chang, Suyon, et al.
Publicado: (2023)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
por: Kurtoglu, Ertugrul, et al.
Publicado: (2014)

Endocrine disorders after heart transplantation: national cohort study
por: Rakusa, Matej, et al.
Publicado: (2020)

Antifailure Therapy Including Spironolactone Improves Left Ventricular Energy Supply‐Demand Relations in Nonischemic Dilated Cardiomyopathy
por: Bell, Susan P., et al.
Publicado: (2014)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
por: Kim, Hyue-Mee, et al.
Publicado: (2021)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Therapeutic Role of Mobilized Bone Marrow Cells in Children with Nonischemic Dilated Cardiomyopathy
por: Habeeb, Nevin M., et al.
Publicado: (2012)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
por: Tompkins, Bryon A., et al.
Publicado: (2018)

Relationship between malnutrition and coronary microvascular dysfunction in patients with nonischemic dilated cardiomyopathy
por: KUL, Şeref, et al.
Publicado: (2020)

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Left Ventricular Noncompaction: A Rare Case of Nonischemic Cardiomyopathy
por: Tian, Julia, et al.
Publicado: (2019)

Biventricular thrombi of nonischemic cardiomyopathy
por: Adnan, Mohammed Muqeet, et al.
Publicado: (2014)

Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022)

Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy
por: Romuk, Ewa, et al.
Publicado: (2019)

Outcomes and predictors of patients with moderate or severe functional mitral regurgitation and nonischemic dilated cardiomyopathy
por: Li, Jiangtao, et al.
Publicado: (2023)

Successful Substrate Ablation for Ventricular Fibrillation in a Patient With Nonischemic Cardiomyopathy
por: Yamaguchi, Junji, et al.
Publicado: (2021)

Left Ventricular Geometry and Replacement Fibrosis Detected by cMRI Are Associated with Major Adverse Cardiovascular Events in Nonischemic Dilated Cardiomyopathy
por: Cojan-Minzat, Bianca Olivia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2c3vk3fnhcqei8adaf0bfsavem